Internal Medicine, Critical Care Medicine · Scottsdale, AZ
NPI
1073856423
Since 2013
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
9060 E Via Linda Ste 250
Scottsdale, AZ, 85258
Phone (480) 614-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$184K
2,426 services
Medicare patients, 2024
597
Average age 74
Drug cost, 2024
$10.2M
3,517 prescriptions
Company payments, 2025
$27K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Akshay Muralidhar was code 99215 (office e&m - established), 486 times for 235 patients. In total Akshay Muralidhar billed 2,426 services in 47 codes, and Medicare paid $184K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 486 | 235 | $135.30 | $66K |
| 94010 Pulmonary Function Testing | Office | 429 | 243 | $19.95 | $8,557 |
| 99233 Hospital E&M - Subsequent | Facility | 238 | 130 | $90.76 | $22K |
| 99214 Office E&M - Established | Office | 185 | 151 | $87.70 | $16K |
| 94618 Pulmonary Function Testing | Office | 135 | 102 | $25.27 | $3,411 |
| 99291 Critical Care E&M | Facility | 130 | 80 | $162.44 | $21K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 111 | 16 | $47.90 | $5,317 |
| 99232 Hospital E&M - Subsequent | Facility | 77 | 41 | $60.67 | $4,672 |
| 94060 Pulmonary Function Testing | Office | 72 | 64 | $28.52 | $2,053 |
| 99223 Hospital E&M - Initial | Facility | 60 | 60 | $133.10 | $7,986 |
| 85018 Blood Count | Office | 52 | 51 | $2.23 | $116 |
| 94729 Pulmonary Function Testing | Office | 51 | 50 | $41.08 | $2,095 |
| 94726 Pulmonary Function Testing | Office | 51 | 50 | $40.62 | $2,071 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 46 | 41 | $12.75 | $587 |
| 99204 Office E&M - New | Office | 43 | 43 | $118.97 | $5,116 |
By year: 2022 $110K for 1,327 services; 2023 $169K for 2,273 services; 2024 $184K for 2,426 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85018 Blood Count | 52 | 51 | $2.23 | $116 |
Medicare prescription drug claims, 2024
In 2024, the drug Akshay Muralidhar prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 329 prescriptions and refills. In total Akshay Muralidhar wrote 3,517 Medicare prescriptions that cost $10.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 329 | 410 | 73 | $259K |
| Furosemide Generic | 238 | 545 | 79 | $888 |
| Tadalafil Generic | 226 | 284 | 35 | $191K |
| Opsumit Macitentan | 213 | 213 | 28 | $2.7M |
| Albuterol Sulfate Hfa Albuterol Sulfate | 210 | 235 | 80 | $6,631 |
| Spironolactone Generic | 174 | 450 | 68 | $2,591 |
| Ambrisentan Generic | 155 | 155 | 18 | $491K |
| Jardiance Empagliflozin | 128 | 325 | 53 | $183K |
| Uptravi Selexipag | 117 | 121 | 17 | $2.9M |
| Montelukast Sodium Generic | 114 | 318 | 47 | $1,504 |
| Potassium Chloride Generic | 99 | 243 | 41 | $2,170 |
| Bumetanide Generic | 97 | 247 | 32 | $3,785 |
| Sildenafil Citrate Generic | 85 | 140 | 16 | $20K |
| Adempas Riociguat | 81 | 81 | Under 11 | $1.1M |
| Prednisone Generic | 81 | 109 | 54 | $381 |
Brand drugs: - claims; generic drugs: 1,805 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Akshay Muralidhar $27K ($27K in general payments such as food, travel and fees) from 24 companies. The largest payer was Merck Sharp & Dohme LLC with $20K.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 32 | $20K |
| Actelion Pharmaceuticals US, Inc. JNJ | 29 | $5,142 |
| United Therapeutics Corporation UTHR | 14 | $696 |
| Insmed, Inc. INSM | 7 | $155 |
| Caris MPI, Inc. | 1 | $140 |
| Johnson & Johnson Health Care Systems Inc. JNJ | 1 | $107 |
| GlaxoSmithKline, LLC. GSK | 5 | $105 |
| Genzyme Corporation SNY | 3 | $78.21 |
| ViiV Healthcare Company GSK | 2 | $68.64 |
| Electromed, Inc. ELMD | 7 | $64.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.